8/16/2019  8:00:22 AM Chg. -0.800 Volume Bid7:57:31 PM Ask7:57:31 PM Market Capitalization Dividend Y. P/E Ratio
15.600EUR -4.88% 0
Turnover: 0.000
-Bid Size: - -Ask Size: - 14.01 bill.EUR - -

Business description

Mylan is a global pharmaceutical company committed to setting new standards in healthcare.
 

Management board & Supervisory board

CEO
Heather Bresch
Management board
Kenneth S. Parks, Anthony Mauro, Rajiv Malik
Supervisory board
Robert J. Coury, Dr. Randall L. Vanderveen, Harry A. Korman, Heather Bresch, JoEllen Lyons Dillon, Mark W. Parrish, Melina Higgins, Neil Dimick, Pauline van der Meer Mohr, Rajiv Malik, Robert J. Cindrich, Sjoerd S. Vollebregt
 

Company data

Name: Mylan N.V.
Address: Building 4, Trident Place, Mosquito Way,UK-Hatfield, Hertfordshire, AL10 9UL
Phone: +44-1707-853-000
Fax: -
E-mail: info@amstock.com
Internet: www.mylan.com
Industry: Healthcare
Sector: Pharmaceutical Industry
Sub sector: Pharmaceuticals
End of financial year: 12/31
Free Float: 70.60%
IPO date: -

Investor relations

Name: Melissa Trombetta
IR phone: +1-724-514-1813
IR Fax: -
IR e-mail: InvestorRelations@mylan.com

Main Shareholders